ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 733906 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 733906; 2) Community: the network communities that were significantly associated with the response to NSC 733906; 3) Molecule: the relationships between components within communities and NSC 733906; 4) MDR: the compounds that were significantly associated with the NSC 733906.

NSC Compound Enrichment Correlation
NSC 38643 Lenamycin 0.0181211508101519 0.0092991347
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.0181211508101519 -0.043931475
NSC 609699 Topotecan hydrochloride 0.0181211508101519 -0.0077708174
NSC 610459 Camptothecin Derivative 0.0181211508101519 -0.11256423
NSC 619859 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- 0.0181211508101519 0.050628891
NSC 643419 Null 0.0181211508101519 0.13259636
NSC 671174 Null 0.0181211508101519 -0.052290556
NSC 673796 9-Acridinamine, 7-methoxy-N-[2-[[2-(dimethylamino)ethyl]amino]ethyl]- 1-nitro- 0.0181211508101519 0.057281659
NSC 681635 Camptothecin Derivative 0.0181211508101519 -0.031942139
NSC 690024 1,4-Butanediamine, N,N'-bis[3-[(phenylmethyl)amino]propyl]-,tetra(trifluoroacetate) 0.0181211508101519 0.064053803
Total:55  Current:17    [First] [Prev] [Next] [Last]